A Personalised Approach Utilising the Frailty Index to Empower Consumers

Status Recruiting

Clinical Trial Summary

Frailty is a common clinical syndrome in older adults that may carry an increased risk for poor health outcomes including falls, hospitalisation, and mortality. Having a colonoscopy can be associated with potential adverse outcomes in frail patients. At present, however, frailty is not routinely assessed in gastroenterological clinical practice. In a prospective randomised controlled study consenting patients over 65 years at the Princess Alexandra Hospital will receive either a) personalised (tailored) approach that includes assessment of frailty and structured information provided to the consumer or b) current standard practice in regards to having a surveillance colonoscopy to determine the effects on patient satisfaction and percentage of colonoscopies avoided.

Clinical Trial Description

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT05292989
Study type	Interventional
Source	Princess Alexandra Hospital, Brisbane, Australia
Contact
Status	Recruiting
Phase	N/A
Start date	August 14, 2023
Completion date	October 26, 2024

View Details

See also
Status	Clinical Trial	Phase
Terminated	`NCT02541357` - Preoperative Relaxation and Intensified Patient Surgery Education in Patients Undergoing Colorectal Surgery	N/A
Active, not recruiting	`NCT02358122` - Determining the Potential of Wholegrain Wheat and Rye to Improve Gut HealTh	N/A
Active, not recruiting	`NCT02442115` - Impact of Improving GI Symptoms on Autism Symptoms and Oxidative Stress
Enrolling by invitation	`NCT00943345` - Validation of New Tests for Gastrointestinal (GI) Permeability	Phase 0
Completed	`NCT00612404` - Symptoms and Endoscopic Results in Consideration of Pretreatment	N/A
Completed	`NCT01127711` - Cohort of Swedish Men	N/A
Recruiting	`NCT05712525` - Gut Recovery In Patients Following Surgery
Recruiting	`NCT06094153` - Prebiotic Effects on Gut Microbiota, Gut Comfort and Immune Function	N/A
Recruiting	`NCT05322486` - Palliative Primary Tumor Resection in Minimally Symptomatic Patients With Colorectal Cancer and Synchronous Unresectable Metastases
Completed	`NCT02486146` - GI Biorepository of Tissue and Bodily Fluids	N/A
Completed	`NCT01816607` - Functional MRI of Hypoxia-mediated Rectal Cancer Aggressiveness
Completed	`NCT00247715` - Comparison of a "Step-Up" Versus a "Step-Down" Treatment Strategy for Patients With New Onset Dyspepsia in General Practice (The DIAMOND-Study)	N/A
Completed	`NCT00035334` - Study of the Safety and Efficacy of NC-503 in Secondary (AA) Amyloidosis	Phase 2/Phase 3
Recruiting	`NCT06286865` - Improving Quality of ICD-10 Coding Using AI: Protocol for a Crossover Randomized Controlled Trial	N/A
Active, not recruiting	`NCT01037049` - Optimum Timing for Surgery After Pre-operative Radiotherapy 6 vs 12 Weeks	Phase 2
Completed	`NCT03725813` - Study Evaluating the Effect of Person-centred Care for Patients Admitted for Inpatient Care at an Internal Medicine Unit	N/A
Recruiting	`NCT05640401` - Holographic Screens as a Replacement of Monitors During GI Endoscopies	N/A
Completed	`NCT02865564` - Effect of Lactobacillus Reuteri DSM17938 in Neonates Treated With Antibiotics	N/A
Completed	`NCT02651857` - Exploratory Study of Upper and Lower Endoscopic Fuse System	N/A
Active, not recruiting	`NCT01984034` - Trial to Assess the Effectiveness of Educational Outreach in Prescription Guidelines	N/A

Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.